Literature DB >> 479172

Adenine nucleotide degradation during energy depletion in human lymphoblasts. Adenosine accumulation and adenylate energy charge correlation.

S S Matsumoto, K O Raivio, J E Seegmiller.   

Abstract

Adenine nucleotide breakdown to nucleosides and purine bases was measured in cultures of human lymphoblastoid cells following: 1) the inhibition of oxidative phosphorylation in the absence of glucose or 2) the addition of 2-deoxyglucose. A mutant cell line, deficient in adenosine kinase, in the presence of an adenosine deaminase inhibitor was used to measure utilization of the two pathways of AMP catabolism involving initial action of either purine 5'-nucleotidase or AMP deaminase. In such a system the appearance of adenosine induced by the oxidative phosphorylation inhibitor, rotenone, implies that approximately 70% of AMP breakdown occurs via dephosphorylation. By the same method, deamination accounts for 82% of AMP breakdown when 2-deoxyglucose is added. The occurrence of AMP dephosphorylation is not correlated with elevated concentrations of substrate or with decreased concentrations of the inhibitors of 5'-nucleotidase, ATP and ADP. Dephosphorylation occurs if, and only if, the adenylate energy charge decreases to about 0.6 in these experiments. In cultures deprived of glucose and oxygen, adenine nucleotide degradation via dephosphorylation results in recovery of normal energy charge values.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479172

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Up-regulated Ectonucleotidases in Fas-Associated Death Domain Protein- and Receptor-Interacting Protein Kinase 1-Deficient Jurkat Leukemia Cells Counteract Extracellular ATP/AMP Accumulation via Pannexin-1 Channels during Chemotherapeutic Drug-Induced Apoptosis.

Authors:  Andrea M Boyd-Tressler; Graham S Lane; George R Dubyak
Journal:  Mol Pharmacol       Date:  2017-05-01       Impact factor: 4.436

2.  Activation of Cl secretion during chemical hypoxia by endogenous release of adenosine in intestinal epithelial monolayers.

Authors:  J B Matthews; K J Tally; J A Smith; A J Zeind; B J Hrnjez
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

3.  Adenosine release from stimulated mast cells.

Authors:  D L Marquardt; H E Gruber; S I Wasserman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

4.  In vitro effects of mycophenolic acid and allopurinol against Leishmania tropica in human macrophages.

Authors:  J D Berman; H K Webster
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

5.  Depletion and recovery of ATP in V79 cells with exposure to inhibitors of glycolysis and oxidative phosphorylation.

Authors:  L L Marden; C R Crawford; R E Bryant
Journal:  In Vitro       Date:  1982-06

6.  Adenosine production inside rat polymorphonuclear leucocytes.

Authors:  A C Newby; C A Holmquist
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

7.  Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.

Authors:  A S Bagnara; M S Hershfield
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  Alterations in nucleotide content of human lung fibroblasts infected with Mycoplasma pneumoniae.

Authors:  S Upchurch; M G Gabridge
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

9.  Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide.

Authors:  I U Schraufstatter; D B Hinshaw; P A Hyslop; R G Spragg; C G Cochrane
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Regulation of platelet AMP deaminase activity in situ.

Authors:  A J Verhoeven; J Marszalek; H Holmsen
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.